Umbilical Cord Mesenchymal Stem Cell Transplantation for Decompensated Hepatitis B Cirrhosis
Status:
Recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the safety and clinical efficacy of umbilical cord mesenchymal
stem cell transplantation for decompensated hepatitis B cirrhosis.
Phase:
N/A
Details
Lead Sponsor:
Asia Stem Cell Regenerative Pharmaceutical Co., Ltd.